05th week of 2012 patent applcation highlights part 41 |
Patent application number | Title | Published |
20120027638 | HIGH-STRENGTH COPPER ALLOY - A high-strength copper alloy contains 20 to 45% of zinc, 0.3 to 1.5% of iron, 0.3 to 1.5% of chromium, and a balance of copper, based on mass. | 2012-02-02 |
20120027639 | ALUMINUM ALLOY FOR DIE CASTING - An alloy for use in die casting having improved thermal conductivity and strength includes at least about 86.0 percent aluminum by weight, from about 9.70 to about 10.70 percent silicon, by weight, from about 0.40 to about 0.70 percent iron, by weight, about 0.25 percent copper, by weight, about 0.50 percent manganese, by weight, from about 0.10 to about 0.20 percent titanium, by weight; and from about 0.010 to about 0.025 percent strontium, by weight. | 2012-02-02 |
20120027640 | Disinfecting Method for Climatic Cabinets - A method for the disinfection of climatic cabinets in particular is provided. The method comprises the following steps: generating a disinfecting hot atmosphere in the space to be disinfected by supplying heat and evaporating water in a heating-up phase; when a temperature of at least 95±5° C. and a relative humidity of at least 80% are reached at a pressure corresponding substantially to the pressure of the ambient atmosphere, maintaining these process conditions in a disinfection phase for a period of time which is sufficient for killing germs situated in the interior space; and subsequently expelling the relative humidity from the space to be disinfected and cooling in a cooling phase, the water vapor generated for disinfection being removed from the space to be disinfected by injecting sterile air in the cooling phase | 2012-02-02 |
20120027641 | METHOD FOR DISINFECTING A BOTTLE - A method for disinfecting a bottle, in particular a baby bottle, including a bottle jacket which is open on both ends, wherein, in a dispensing position, a bottom cap is fastened to a bottom-side opening and a teat is fastened to a teat-side opening by a fastening ring, the inner periphery of the bottom-side opening being larger than the outer periphery of the fastening ring, wherein, for transfer into a disinfection position, the bottom cap is removed from the bottle jacket, the teat and the fastening ring are placed onto the bottom cap and introduced into the bottle jacket, the bottom cap is attached to the bottom-side opening, a disinfectant is filled into the bottle jacket before the bottle is heated for disinfection. | 2012-02-02 |
20120027642 | Luminometer or Fluorometer with an Injection Device - Described is a luminometer or fluorometer having an optical axis which extends essentially perpendicular to the measuring sample. The detector for the luminometer or the fluorometer is arranged either directly or via a deflection means in the optical axis. An injection device ( | 2012-02-02 |
20120027643 | Process and apparatus for generating hydrogen - A solution is to be created, with a method and a device for generating hydrogen, in which silicon and/or an alloy that contains silicon is reacted in a reaction vessel ( | 2012-02-02 |
20120027644 | Handheld Sterilization Device - Embodiments of the disclosed technology comprise a handheld cleaning device that sanitizes an item to be cleaned by, in a single action, dispensing ozone and ultrasonic wave cavitations in an aqueous medium that contains the object to be cleaned. The handheld device comprises a dipping end, which further comprises an ozone generator, dispensing ozone from the dipping end, and an ultrasonic wave generator generating ultrasonic cavitation in an aqueous medium. The device is configured to be held on a holding end, with a side opposite the holding end configured for dipping into an aqueous medium (e.g., water, cleaning fluid, liquids, etc.) which is contained in a vessel. The vessel is a concave structure capable of holding such aqueous medium, such as a sink, a bowl, a basin, and the like. | 2012-02-02 |
20120027645 | PROCESSING APPARATUS FABRICATION - A processing apparatus that is formed from a plurality of metal layers that are stacked and aligned together and then connected together to form one or more portions of the processing apparatus. | 2012-02-02 |
20120027646 | Reaction Chamber of an Epitaxial Reactor and Reactor That Uses Said Chamber - The present invention relates to a reaction chamber of an epitaxial reactor that essentially consists of a quartz piece; the quartz piece comprises a quartz piece portion ( | 2012-02-02 |
20120027647 | Stimulus indicator employing stimulus sensitive metals and gels - The present invention relates, for example, to a stimulus-indicating device. More particularly, the present invention includes an apparatus for evidencing when a stimulus sensitive product has been exposed to a designated or predetermined stimulus for a certain period of time, and the invention further may include a method for manufacturing aspects of that apparatus. | 2012-02-02 |
20120027648 | INTERFACING CAPS FOR MICROFLUIDIC DEVICES AND METHODS OF MAKING AND USING THE SAME - An interfacing cap for a reagent storage vessel is provided. The interfacing cap comprises a partitioning element having a structure corresponding to an opening of the reagent storage vessel, a projection fitting disposed on the partitioning element, a holder element, and a puncturing element coupled to the projection fitting. | 2012-02-02 |
20120027649 | MOUNTING MEDIA DEVICE - A mounting media device for application of mounting media to a specimen positioned on a slide before placement of a cover slip. The mounting media device includes a housing, a tray component, a mounting media transfer component, a dispenser component, and a control element. The mounting media transfer component provides mounting media to the dispenser component. In an automatic mode, a sensor may provide a signal to the control element to cause mounting media to be transferred from the mounting media transfer component to the dispenser component automatically. The dispenser component may dispense the mounting media to the tray component and onto a specimen positioned on a slide before placement of a cover slip. In a manual mode, a trigger element may be depressed so that the mounting media device may be manually controlled and release mounting media from the dispenser component. | 2012-02-02 |
20120027650 | METHODS AND DEVICES FOR PREPARING MICROSCOPY SAMPLES - A system for preparing and holding specimens for microscopic analysis including a capsule having an open end, an opposite end including at least one aperture and a reservoir. The system also includes an insert with a base including at least one aperture. The insert fits within and engages an inner wall of the reservoir to secure the insert within the reservoir. The system also includes an insertion tool configured to engage the insert. The insertion tool is sized to position the insert within the reservoir at a variety of positions within the reservoir. The insertion tool will disengage the insert once the insert is positioned within the reservoir. A method of positioning a specimen within a capsule for processing the specimen in preparation for microscopic analysis. A tray for holding a plurality of pipette tips in such a way that a lower end of each pipette tip is sealed. | 2012-02-02 |
20120027651 | METHOD FOR RECOVERY OF RARE EARTHS FROM FLUORESCENT LAMPS - Method of recovery of rare earths from fluorescent lamps. The method comprises six steps. The individual process steps are: Mechanical separation of coarse components. Separation of the halophosphate. Extraction in acids of easily soluble rare-earth fluorescent substances (mainly Y, Eu-oxide) Extraction in acids of rare earth fluorescent substances which dissolve with difficulty (for example rare-earth phosphates) Breakdown of the remaining components which contain rare earths (for example rare-earth-aluminates) Final treatment. | 2012-02-02 |
20120027652 | METATHETIC COPPER CONCENTRATE ENRICHMENT - In one aspect, the invention provides processes for producing an enriched copper concentrate from a copper-and-nickel-containing ore. Processes of the invention may include an initial step of comminuting the ore, to provide a ground ore comprising copper minerals and nickel minerals. The ground ore may be subjected to a floatation process, to separate the ground ore into distinct fractions, such as first and second concentrates. A first concentrate may for example be made up of copper-enriched-and-nickel-containing solids, while a second concentrate is made up of nickel-enriched-and-copper-containing solids. The floatation process may for example fractionate the ore so that the concentration of copper minerals is higher in the first concentrate than in the ore, and the concentration of the nickel minerals is higher in the second concentrate than the ore. | 2012-02-02 |
20120027653 | CATALYTIC COMPOSITION FOR TREATING COAL COMBUSTION GASES, METHOD FOR PREPARING SAME, CATALYTIC SYSTEM INCLUDING SAME, AND USE THEREOF - The invention relates to a catalytic composition for treating coal combustion gases, to a method for preparing said composition, to a catalytic system having such a composition, and to the use of the catalytic composition for treating coal combustion gases. The catalytic composition is made of particles of a solid composition cCeO | 2012-02-02 |
20120027654 | CATALYST FOR PURIFICATION OF EXHAUST GAS | 2012-02-02 |
20120027655 | Method and Apparatus for Adjustably Treating a Sour Gas - A feed gas comprising CO | 2012-02-02 |
20120027656 | Method and Apparatus for Treating a Sour Gas - A feed gas comprising CO | 2012-02-02 |
20120027657 | CONTROL SYSTEM FOR UV-PCO AIR PURIFIER - Ultraviolet photocatalytic oxidation (UV-PCO) air purification system includes controller that coordinates operation of photocatalytic reactor that removes volatile organic compounds from air and a regeneration mode that removes contaminants adsorbed in UV-PCO system. Controller coordinates operation of the regeneration mode and photocatalytic reactor so that when air purification system is turned on, the regeneration mode begins to operate before photocatalytic reactor is activated. The initial operation of the regeneration mode allows contaminants that have adsorbed in UV-PCO system to be removed before controller initiates a normal operation mode by activating photocatalytic reactor to cleanse the air. | 2012-02-02 |
20120027658 | Oxidation Catalysts Useful for Ambient Temperature Operation - A catalytic sorbent material includes a porous support composed of a hydroxylated metal oxide, preferably hydroxylated zirconia, and catalytic metal nanoparticles, preferably gold nanoparticles, loaded on the porous support. These catalysts can be utilized to convert carbon monoxide into carbon dioxide at relatively low temperatures. | 2012-02-02 |
20120027659 | CO SHIFT CATALYST, CO SHIFT REACTOR, AND METHOD FOR PURIFYING GASIFIED GAS - A CO shift catalyst according to the present invention reforms carbon monoxide (CO) contained in gas. The CO shift catalyst is prepared from one or both of molybdenum (Mo) and cobalt (Co) as an active ingredient and an oxide of one of, or a mixture or a compound of, titanium (Ti), silicon (Si), zirconium (Zr), and cerium (Ce) as a carrier for supporting the active ingredient. The CO shift catalyst can be used in a halogen-resistant CO shift reactor ( | 2012-02-02 |
20120027660 | METHODS TO RECOVER AND PURIFY SILICON PARTICLES FROM SAW KERF - The present disclosure generally relates to methods for recovering silicon from saw kerf, or an exhausted abrasive slurry, resulting from the cutting of a silicon ingot, such as a single crystal or polycrystalline silicon ingot. More particularly, the present disclosure relates to methods for isolating and purifying silicon from saw kerf or the exhausted slurry, such that the resulting silicon may be used as a raw material, such as a solar grade silicon raw material. | 2012-02-02 |
20120027661 | PROCESS AND REACTOR SYSTEM FOR PRODUCING AMMONIA USING IONIC LIQUIDS - A process and a reactor system for producing ammonia is described. The ammonia produced, such as by the Haber process, is absorbed into an ionic liquid. The removal of ammonia shifts the reaction equilibrium toward the production of ammonia, resulting in higher yields of ammonia. | 2012-02-02 |
20120027662 | INDUCTION HEATED GASIFIER - A method of removing organic components from a mixture containing organic and inorganic components which method involves providing an induction heated screw conveyor having an auger and passing the mixture through the induction heated screw conveyor while inductively heating the auger so as to heat the mixture in the induction heated screw conveyor primarily from the center of the induction heated screw conveyor. The mixture is heated to a temperature that is sufficient to cause the organic components in the mixture to separate from the mixture as a vapor. The oxygen concentration in the induction heated screw conveyor is controlled so as to gasify the organic components. The gasified organic components are removed and the remaining inorganic components are collected. | 2012-02-02 |
20120027663 | CARBON DIOXIDE CAPTURE SYSTEM AND METHODS OF CAPTURING CARBON DIOXIDE - In one embodiment, a system for recovering carbon dioxide can comprises: a reaction chamber having a first pressure and comprising a gas stream inlet; a phase-changing liquid sorbent, wherein the liquid sorbent is chemical reactive with carbon dioxide to form a solid material; a regeneration unit to decompose the solid material to released carbon dioxide gas and regenerated liquid sorbent; and a dry transport mechanism configured to transport the solid material from the reaction chamber at the first pressure to the regeneration unit at a second higher pressure. In one embodiment, a method of recovering carbon dioxide from a gas stream, comprises: chemically reacting carbon dioxide with a liquid sorbent to form a solid material; without adding a carrier fluid, dry pressurizing and transporting the solid material, to a regeneration unit; and heating the solid material in the regeneration unit to decompose the solid material to carbon dioxide gas and regenerated liquid sorbent. | 2012-02-02 |
20120027664 | CARBON DIOXIDE CAPTURE SYSTEM AND METHODS OF CAPTURING CARBON DIOXIDE - In one embodiment, a system for recovering carbon dioxide from a gas stream, comprising: a reaction chamber having a first pressure and comprising a gas stream inlet; a phase-changing liquid sorbent, wherein the liquid sorbent is chemically reactive with carbon dioxide to form a solid material; a regeneration unit to decompose the solid material to released carbon dioxide gas and regenerated liquid sorbent; and a transport mechanism disposed between the reaction chamber and the regeneration unit and configured to mix the solid material with a liquid to form a slurry, pressurize the slurry, and transport the slurry to the regeneration unit. In one embodiment, a method of recovering carbon dioxide from a gas stream, comprising: chemically reacting carbon dioxide with a phase-changing liquid sorbent to form a solid material; mixing the solid material with a liquid to form a slurry; pressurizing and transporting the slurry to a regeneration unit; and heating the slurry to form carbon dioxide gas and regenerated liquid sorbent. | 2012-02-02 |
20120027665 | CATALYST COMPRISING RUTHENIUM AND SILVER AND/OR CALCIUM FOR THE OXIDATION OF HYDROGEN CHLORIDE - Catalyst comprising ruthenium on a support for the catalytic oxidation of hydrogen chloride by means of oxygen to form chlorine, wherein the catalyst comprises from 0.01 to 10% by weight of silver and/or calcium as dopant. | 2012-02-02 |
20120027666 | POLYOXOMETALATE WATER OXIDATION CATALYSTS AND METHODS OF USE THEREOF - Homogeneous water oxidation catalysts (WOCs) for the oxidation of water to produce hydrogen ions and oxygen, and methods of making and using thereof are described herein. In a preferred embodiment, the WOC is a polyoxometalate WOC which is hydrolytically stable, oxidatively stable, and thermally stable. The WOC oxidized waters in the presence of an oxidant. The oxidant can be generated photochemically, using light, such as sunlight, or electrochemically using a positively biased electrode. The hydrogen ions are subsequently reduced to form hydrogen gas, for example, using a hydrogen evolution catalyst (HEC). The hydrogen gas can be used as a fuel in combustion reactions and/or in hydrogen fuel cells. The catalysts described herein exhibit higher turn over numbers, faster turn over frequencies, and/or higher oxygen yields than prior art catalysts. | 2012-02-02 |
20120027667 | Method for the production of hydrogen peroxide - A process for production of hydrogen peroxide which comprises the following steps: (a) hydrogenation of a working solution comprising at least one non-ionic quinone compound selected from the group consisting of anthraquinone and its derivatives, phenanthrenequinone and its derivatives, naphthoquinone and its derivatives, and benzoquinone and its derivatives, wherein the total molecular weight of optional groups attached to the quinone skeleton is lower than 500, to obtain at least one corresponding hydroquinone compound; (b) oxidation of the at least one hydroquinone compound to obtain hydrogen peroxide; and (c) separation of the hydrogen peroxide, during and/or subsequently to the oxidation step b); wherein the working solution of either step a) and/or b) comprises less than 30% by weight of organic solvent. | 2012-02-02 |
20120027668 | LOW VALENCE TITANIUM OXIDES AND METHOD OF PRODUCING THE SAME - The object of the present invention is to provide a method of producing low valence titanium oxides in a steady supply manner acceptable in industrial production. The low valence titanium oxides are produced by electrical discharge between two electrodes in an aqueous medium, wherein at least one of the electrodes is a titanium-containing electrode. | 2012-02-02 |
20120027669 | METHOD OF USE OF AN IONIC LIQUID FOR STORING HYDROGEN - A method of storing hydrogen is provided, wherein the method comprises forming a first ionic liquid by inducing a borohydride into a second ionic liquid comprising cations and an anion comprising borate, in particular metaborate, and forming the second ionic liquid by releasing the hydrogen out of the first ionic liquid by using water and/or a catalyst. | 2012-02-02 |
20120027670 | SELF SUSTAINED ELECTROCHEMICAL PROMOTION CATALYSTS - A method and system for the reduction of pollutant NOx gases from automobile exhaust, as well as a method of reforming hydrocarbons, using a self-sustaining catalyst comprising an ion conductive support, a dispersed cathodic phase, a dispersed anodic phase, and a dispersed sacrificial phase, and a method of forming the self-sustaining catalyst. | 2012-02-02 |
20120027671 | HYDROGEN-GENERATING MATERIAL AND METHOD FOR PRODUCING HYDROGEN - A hydrogen-generating material and method for generating hydrogen are provided. A plurality of metal particles and a plurality of modifier particles are mixed and then reacted with water to generate hydrogen. The metal particles are made of material including aluminum or aluminum alloy or combination thereof. The modifier particles preferably comprise titanium dioxide (TiO | 2012-02-02 |
20120027672 | HYDROGEN-GENERATING MATERIAL AND METHOD FOR GENERATING HYDROGEN - A hydrogen-generating material and method for generating hydrogen are provided. A plurality of metal particles and a plurality of modifier particles are mixed and than reacted with water to generate hydrogen. The metal particles are made of material including aluminum or aluminum alloy or combination thereof. The modifier particles preferably comprise titanium dioxide (TiO | 2012-02-02 |
20120027673 | SYNTHESIS OF HIERARCHICAL NANOCRYSTALLINE ZEOLITES WITH CONTROLLED PARTICLE SIZE AND MESOPOROSITY - A one step synthesis of nanocrystalline zeolites ZSM-5 and Naβ from a single template system in high yield has been discovered. The size of individual nanocrystals, as well as mesopore surface area and pore volume can be controlled by adjusting the pH of the reaction mixture, as well as the hydrothermal treatment temperature and duration. The mesopore volume and size distribution show a dependence on particle size such that smaller particles lead to higher mesopore volumes and narrower pore size distributions. | 2012-02-02 |
20120027674 | IL-18 RECEPTOR AS A NOVEL TARGET OF REGULATORY T CELLS IN CANCER - Compositions and methods for use in preventing, inhibiting or reducing tumor cell growth comprising an effective amount of an active agent that kills IL-18 Receptor expressing T cells in admixture with a suitable diluent or carrier are described herein. | 2012-02-02 |
20120027675 | TARGETING PULMONARY EPITHELIUM USING ADRP - This invention provides novel compositions and methods for the specific and/or preferential delivery of an effector (e.g. a drug or label) to an epithelial cell (e.g. a pulmonary epithelium). The compositions comprise an adipocyte differentiation-related protein (ADRP) attached to an effector thereby forming a chimeric moiety. The chimeric moiety is preferentially delivered to epithelial cells. | 2012-02-02 |
20120027676 | MODIFIED SODIUM IODIDE SYMPORTER PROTEINS AND USES THEREOF - A modified sodium iodide symporter (NIS) protein is provided. The modified NIS protein comprises an amino acid sequence of SEQ ID NO.1 with the proviso that at least one amino acid residue within SEQ ID NO. 1 is changed. The modified NIS protein has an enhanced transport function, and the expression of the modified NIS protein in the cells results in higher intracellular levels of a substrate of a NIS protein than does the expression of the same amount of a wild-type NIS protein. | 2012-02-02 |
20120027677 | Prion-specific peptoid reagents - The invention relates to peptoid reagents that interact preferentially with a pathogenic form of a conformational disease protein as compared to a nonpathogenic form of the conformational disease protein where the peptoid reagent comprises an amino-terminal region, a carboxy-terminal region, and at least one peptoid region between the amino-terminal region and the carboxy-terminal region where the peptoid region comprises 3 to about 30 N-substituted glycines, and optionally one or more amino acids. The invention also relates to methods of using the peptoids in detecting and isolating prions, and in the treatment and prevention of prion-related diseases. | 2012-02-02 |
20120027678 | METHOD OF USING STEM CELLS TO AID IN DIAGNOSIS - The present invention provides a method for the in vitro culture of embryonic stem cells, wherein the stem cells continue to express no antigen or antigen CD117, and mostly remain undifferentiated during culture. The present invention also relates to purified preparations of embryonic stem cells and for uses of embryonic stem cells in treating a wide variety of conditions, diseases and disorders. | 2012-02-02 |
20120027679 | CONTRAST AGENT FOR PHOTOACOUSTIC IMAGING AND PHOTOACOUSTIC IMAGING METHOD USING THE SAME - It is intended to provide a novel contrast agent for photoacoustic imaging that is highly capable of binding to a target molecule and generates high photoacoustic signals. The present invention provides a contrast agent for photoacoustic imaging represented by Formula 1: | 2012-02-02 |
20120027680 | OXIME CONJUGATES AND METHODS FOR THEIR FORMATION AND USE - The present invention relates to biodegradable biocompatible polyketals, methods for their preparation, and methods for treating animals by administration of biodegradable biocompatible polyketals. In one aspect, a method for forming the biodegradable biocompatible polyketals comprises combining a glycol-specific oxidizing agent with a polysaccharide to form an aldehyde intermediate, which is combined with a reducing agent to form the biodegradable biocompatible polyketal. The resultant biodegradable biocompatible polyketals can be chemically modified to incorporate additional hydrophilic moieties. A method for treating animals includes the administration of the biodegradable biocompatible polyketal in which biologically active compounds or diagnostic labels can be disposed. | 2012-02-02 |
20120027681 | Low-Aspect Ratio Carbon Nanostructures - Low-aspect ratio nanostructures, such as nanocups, nanorings, and arrays of nanocups and nanorings, methods of fabrication of nanostructures, and methods of using nanostructures are disclosed. | 2012-02-02 |
20120027682 | Pyrazine Derivatives for Optical Imaging and Therapy - The invention provides compounds, including compositions, preparations and formulations, and methods of using and making such compounds. Compounds of the present invention include pyrazine derivatives having a pyrazine core and a plurality of substituents. In some embodiments, pyrazine derivatives of the invention are pyrazine core compounds having one or more electron donating groups and one or more electron withdrawing groups optionally functionalized to provide useful optical, biological, pharmacokinetic and/or physical properties. | 2012-02-02 |
20120027683 | DIABETES T CELL RECEPTORS - T cell receptors (TCRs) having the property of binding to a murine insulin-derived peptide, LYLVCGERG (SEQ ID NO:62), presented by the murine H-2K | 2012-02-02 |
20120027684 | CANCER THERAPY BASED ON TUMOR ASSOCIATED ANTIGENS DERIVED FROM CYCLIN D1 - The present invention relates to cyclin D1-derived peptides for use in the improved treatment of cancer in a patient, particularly in the form of a combination therapy using a vaccine. Other aspects relate to the use of the peptides or a combination thereof as a diagnostic tool. | 2012-02-02 |
20120027685 | DETERMINING THE CAPABILITY OF A TEST COMPOUND TO AFFECT SOLID TUMOR STEM CELLS - A small percentage of cells within an established solid tumor have the properties of stem cells. These solid tumor stem cells give rise both to more tumor stem cells and to the majority of cells in the tumor that have lost the capacity for extensive proliferation and the ability to give rise to new tumors. Thus, solid tumor heterogeneity reflects the presence of tumor cell progeny arising from a solid tumor stem cell. We have developed a xenograft model in which we have been able to establish tumors from primary tumors via injection of tumor cells in the mammary gland of severely immunodeficient mice. These xenograft assay have allowed us to do biological and molecular assays to characterize clonogenic solid tumor stem cells. We have also developed evidence that strongly implicates the Notch pathway, especially Notch 4, as playing a central pathway in carcinogenesis. | 2012-02-02 |
20120027686 | HK1-BINDING PROTEINS - The invention features hK1 binding polypeptides as well as compositions comprising such polypeptides and methods of making and using such polypeptides. | 2012-02-02 |
20120027687 | FATTY ACID PROTEIN KINASE C ACTIVATORS AND ANTICOAGULANT FOR THE TREATMENT OF STROKE - The present disclosure provides a method for treating stroke by administering an anticoagulant, e.g., recombinant tissue plasminogen activator (rTPA), and a protein kinase C(PKC) activator, wherein the PKC activator may be administered before, after, or at the same time as the rTPA. The methods disclosed herein may limit the size of infarction and/or reduce mortality, the disruption of the blood-brain barrier, and/or the hemorrhagic damage due to ischemic stroke compared with rTPA administration alone; and may also extend the therapeutic time window for administering rTPA after a stroke. Also disclosed are compositions and kits comprising rTPA and a PKC activator for treating stroke. | 2012-02-02 |
20120027688 | PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND - The present invention describes processes for the preparation of a lipid blend and a uniform filterable phospholipid suspension containing the lipid blend, such suspension being useful as an ultrasound contrast agent. | 2012-02-02 |
20120027689 | METHODS AND COMPOSITIONS FOR ALTERING PHOTOPHYSICAL PROPERITES OF FLUOROPHORES VIA PROXIMAL QUENCHING - The invention is directed to fluorophore-containing compositions and configurations wherein proximity between the fluorophore and one or more protective agents (PAs) modifies the lifetime of fluorescent and/or dark states, their frequency of occurrence, and the total lifetime of fluorescence in order to appropriately modify the photophysical characteristics of the fluorophore. The invention is also directed to methods that utilize these compositions and configurations. | 2012-02-02 |
20120027690 | PH-SENSITIVE GRAFT COPOLYMER, MANUFACTURING METHOD FOR SAME, AND POLYMER MICELLES USING METHOD - The present document relates to a manufacturing method for pH-sensitive graft polymer micelles and a polymer micelle-type pharmaceutical composition containing the graft copolymer. The pH-sensitive graft copolymer micelles are usable as various markers and contrast agents for various molecular images for the diagnosis and treatment of diseases and a carrier for delivery of various medicines according to disease. The pH-sensitive graft copolymer forms micelles that can be used in target-oriented diagnosis and medicine release according to changes in the pH of a body. The polymer micelles are provided by inducing a graft copolymer of poly(β-amino ester) compounds which has a solubility in water depending on pH but is incapable of forming the micelles due to a self-assembly phenomenon, and hydrophilic poly(ethylene glycol) compounds. | 2012-02-02 |
20120027691 | Cinnamic Acid-Based Oligomers and Uses Thereof - Cinnamic acid-based oligomers and therapeutic uses thereof are provided. The oligomers are used as anti-inflammation agents, inhibitors of elastase and anti-oxidants, and in some cases (e.g. the treatment of lung disorders such as lung cancer) all three activities are simultaneously beneficial. Subsets of the oligomers (e.g. β-O4 and β-5 trimers and tetramers) are used as anticoagulants. | 2012-02-02 |
20120027692 | PYRROLOPYRIMIDINEDIONE AND ITS THERAPEUTIC USE - The compound of formula (I) is an inhibitor of human neutrophil elastase, useful for inhalation treatment of pulmonary inflammation. | 2012-02-02 |
20120027693 | METHODS AND COMPOSITIONS FOR PREVENTING AND RELIEVING MUSCLE CRAMPS AND FOR RECOVERY FROM NEUROMUSCULAR IRRITABILITY AND FATIGUE FOLLOWING EXERCISE - The methods and compositions of the present invention are directed to the treatment or amelioration of muscle cramps using a composition that includes one or more TRPV1 channel activators, and/or one or more TRPA1 channel activators, and/or one or more ASIC channel activators. | 2012-02-02 |
20120027694 | INDUCIBLE RELEASE VEHICLES - This invention relates to inducible release vehicle comprised of crosslinked carbohydrates or proteins and an active ingredient. The release is induced by an external stimulus, e.g. an enzyme such as amylase. Such a vehicle can particularly be used in an applications for preventing microbial decay or combating microbial infections. Other uses are for oral applications such as providing anti-caries or flavoring compounds and for pharmaceutical and/or nutraceutical applications. | 2012-02-02 |
20120027695 | WATER-ABSORBENT ADHESIVE COMPOSITIONS AND ASSOCIATED METHODS OF MANUFACTURE AND USE - An adhesive composition is provided that is water-insoluble yet water-absorbent, i.e., capable of absorbing up to 15 wt. % water or more. The composition in composed of a film-forming hydrophilic polymer with at least one linear segment having a plurality of recurring polar groups along the polymer backbone, a complementary multifunctional polymer with a plurality of recurring functional groups that noncovalently bind to the polar groups on the film-forming polymer, and plasticizer. A method for manufacturing the adhesive composition is provided as well. | 2012-02-02 |
20120027696 | DENTIFRICE COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING DAMAGE TO TOOTH SURFACES - The invention encompasses compositions and methods for treating and modifying surfaces of teeth, which compositions include calcium and magnesium containing silicates or silica, cationic polymer modified silica or combinations thereof. The composition when applied to the teeth or a tooth surface deposit on such surfaces to repair acid damaged enamel and prevent further erosion of a tooth surface. | 2012-02-02 |
20120027697 | PLANT EXTRACTS, COMPOSITIONS CONTAINING SAME, AND USES THEREOF - This disclosure relates to plant extracts selected from | 2012-02-02 |
20120027698 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS - Disclosed herein is a cosmetic and/or pharmaceutical composition comprising, in a physiologically acceptable medium, at least one (co)polymer comprising a polymer backbone and at least one junction group linked to the polymer backbone and capable of establishing H bonds with at least one partner junction group, each pairing of a junction group involving at least 3H bonds, wherein the at least one (co)polymer comprises at least one ionizable group. Also disclosed herein is a cosmetic treatment process comprising applying the composition to keratin materials. | 2012-02-02 |
20120027699 | SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED MONOAMINES - Skin care compositions comprising certain substituted monoamines, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin. | 2012-02-02 |
20120027700 | SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED DIAMINES - Skin care compositions comprising certain substituted diamines, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin. | 2012-02-02 |
20120027701 | Canna and Shea Topical Cream - A THC composition comprises cannabis leaves simmered in butter, which is then filtered and cooled, and then mixed with shea butter. The resulting compound is used for topical skin relief, sun protection for skin and other uses. The butter used for simmering the cannabis leaves may be cow butter, sheep butter, olive oil, cooking oil, and other compositions. | 2012-02-02 |
20120027702 | VOLATILE OILY COMPOSITION - A volatile oily composition includes from 50 to 100% by weight of a mixture of paraffins and from 0 to 50% by weight of at least one non-volatile oil. Cosmetic compositions containing the abovementioned oily composition, and the cosmetic uses of the cosmetic compositions, particularly for making up and/or caring for and/or protecting skin, lips, eyelashes and/or nails, and in antiperspirant/deodorant compositions are also described. | 2012-02-02 |
20120027703 | NOVEL PROTEASOME-ACTIVATING ANTI-AGING PEPTIDES AND COMPOSITIONS CONTAINING SAME - The present invention relates to peptidic compounds of general formula (I): | 2012-02-02 |
20120027704 | USE OF ORGANOMODIFIED SILOXANES BRANCHED IN THE SILICON PART FOR PRODUCING COSMETIC OR PHARMACEUTICAL COMPOSITIONS - The invention relates to organomodified additives, emulsifiers, dispersants and/or active nourishing ingredients present in the silicon part of branched siloxane block copolymers, to the use thereof, in particular for producing cosmetic, dermatological or pharmaceutical formulations as well as care and cleansing products, and to the preparations as such. | 2012-02-02 |
20120027705 | ADMINISTRATION OF CELLS AND CELLULAR EXTRACTS FOR REJUVENATION - The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring aged or damaged skin to a healthy appearance. In some embodiments, the invention relates to compositions of cells, eggs, cell extracts, egg extracts, and extract components such as purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products. | 2012-02-02 |
20120027706 | METHODS FOR TREATING SKIN PIGMENTATION - This invention relates to methods and compositions for bringing about changes in skin pigmentation. More particularly, this invention relates to compounds which affect melanogenesis and can be used as depigmenting agents or as agents for darkening skin utilizing the PAR-2 pathway. | 2012-02-02 |
20120027707 | LYCOGEN EXTRACT, COMPOSITION THEREOF AND METHOD FOR THE TREATMENT USING THE SAME - A lycogen extract comprising active ingredient of ζ-carotene, neurosporene, spheroidenone and/or methoxyneurosporene is described. A composition comprising the lycogen extract of the present invention and food scientific or pharmaceutical acceptable carrier is also presented. A method for the treatment of disease in need of the lycogen extract which comprises administering to a patient in need thereof a therapeutically effective amount of lycogen extract of the present invention is further described. | 2012-02-02 |
20120027708 | Organopolysiloxane Compositions And Their Production - This invention relates to the polymerization of organopolysiloxanes to form organopolysiloxanes of increased molecular weight and to the organopolysiloxane compositions thus produced. The organopolysiloxane is in admixture with a molten wax during the polymerization, thereby forming a blend of the wax with an organopolysiloxane of increased molecular weight. After the polymerisation reaction is completed, the reaction product can be cooled below the solidification temperature of the wax, for example down to room temperature. This yield a paste-like solid blend which is a very intimate dispersion of wax in organopolysiloxane or vice versa. The dispersion is surprisingly stable. | 2012-02-02 |
20120027709 | LIPOPHILICALLY SURFACE-TREATED POWDER HAVING EASY DISPERSABILITY AND COSMETIC BLENDED WITH SUCH A POWDER - Provided is a surface-treated powder, in which a powder is treated with a surface-treating agent composed of a mixture A+B including A: an alkyl alkoxy silane of a general formula (1): (C | 2012-02-02 |
20120027710 | Hairstyling Cosmetic - The present invention provides a hairstyling cosmetic that applies easily; fits smoothly to hair; thickens thus has a superior hairstyling capacity immediately after application; and has suitable setting capacity, re-hairstyling capacity, and non-stickiness because upon completion of hairstyling, entire solvent volatilizes and a hairstyling component precipitates. The hairstyling cosmetic of the present invention is characterized by comprising:
| 2012-02-02 |
20120027711 | FIXATIVE POLYMER COMPATIABLE WITH HAIR STYLING COMPOSITION - A polymer with good compatibility comprising one or more non-ionic water soluble monomers, such as poly(ethylene glycol)(meth)acrylate (PEGMA), is provided that is suitable for use in aerosol hair styling formulations which have improved clarity. There is also provided a hair styling composition comprising (a) one or more fully soluble polymer, and (b) a solvent mixture, and optional other ingredients. | 2012-02-02 |
20120027712 | Solubilized Composition - This invention provides a solubilized composition in which a cyclic or straight silicone oil is solubilized in a large amount and stably. The solubilized composition is characterized by comprising (a) a polyoxyethylene alkyl ether type nonionic surfactant represented by the following formula (I): | 2012-02-02 |
20120027713 | Odor Elimination Composition for Use on Soft Surfaces - A method and composition for deodorizing soft surfaces such as carpeting and upholstery are disclosed. The method includes the spraying of a liquid composition on a soft surface and allowing the composition to absorb into the soft surface, form liquid agglomerations within the soft surface to the agglomerations can make contact with malodorants disposed within the soft surface. The composition is capable of penetrating rapidly and deeply into the soft surfaces for contacting odor-causing substances embedded therein. The composition comprises an active ingredient such as a glycol or triethanolamine. Other ingredients that contribute to the surface penetration and/or agglomeration formation include ethanol, water, fragrance and a combination of at least one nonionic and at least one ionic surfactant. | 2012-02-02 |
20120027714 | Segmented Polymers and Their Conjugates - Segmented water soluble polymers, containing a higher molecular weight segment linked to a lower molecular weight segment, are described. In one embodiment, the polymer segments are poly(ethylene glycol) segments. The segmented polymers are functionalized and are useful for conjugation to various moieties such as pharmacologically active substances. Also described are conjugates of such polymers and methods of their preparation. | 2012-02-02 |
20120027715 | POLYMER FILMS WITH EMBEDDED IODINATED RESIN AND METHODS OF MANUFACTURING SAME - The disclosure relates to polymer films containing iodinated resin, where such films have advantageous antibacterial and/or antitoxic properties. The films may be used, for example, in medical tape, wound dressings and bandages. In certain embodiments, the invention is also directed to methods of manufacturing such polymer films, where various manufacturing difficulties have been addressed and overcome. | 2012-02-02 |
20120027716 | Povidone Iodine, A Novel Alternative Preservative For Ophthalmic Compositions - The invention includes a preserved ophthalmic preparation comprising povidone-iodine (PVP-I) at a concentration sufficient to preserve the ophthalmic preparation, and at least one member selected from the group consisting of a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial compound, an anti-allergy compound, and an anti-glaucoma compound. The invention also includes adding PVP-I to an ophthalmic composition in order to preserve the composition, wherein the PVP-I is added at a concentration sufficient to preserve the composition. | 2012-02-02 |
20120027717 | TREATMENT METHODS USING DISINFECTING COMPOSITIONS CONTAINING A POLYMER COMPLEX OF ORGANIC ACID - The present invention provides compositions which not only effectively kill a broad spectrum of microorganisms present on surfaces on contact but continue to kill microorganisms for a period of time thereafter. | 2012-02-02 |
20120027718 | COMBINATION THERAPY WITH GLATIRAMER ACETATE AND RASAGILINE FOR THE TREATMENT OF MULTIPLE SCLEROSIS - The subject invention provides a method of treating a subject afflicted with a form of multiple sclerosis comprising periodically administering to the subject an amount of glatiramer acetate and an amount of rasagiline or the pharmaceutically acceptable salt thereof, wherein the amounts when taken together are effective to alleviate a symptom of the form of multiple sclerosis in the subject so as to thereby treat the subject. The subject invention also provides a package comprising glatiramer acetate, rasagiline or the pharmaceutically acceptable salt thereof and instructions for use of the together to alleviate a symptom of a form of multiple sclerosis in a subject. The subject invention further provides a pharmaceutical combination comprising separate dosage forms of an amount of glatiramer acetate and an amount of rasagiline or the pharmaceutically acceptable salt thereof, which combination is useful to alleviate a symptom of a form of multiple sclerosis in a subject. | 2012-02-02 |
20120027719 | Polyester Based Degradable Materials and Implantable Biomedical Articles Formed Therefrom - A method of making an aliphatic polyester prepolymer, comprising: reacting, alone or in combination with other reactants, a diol with at least a first diacid (or a diester of said first diacid) to produce an aliphatic polyester prepolymer. The first diacid is preferably a trans-beta-hydromuconic acid (HMA). In some embodiments, the diol contains at least one ether linkage. In some embodiments the diol is further reacted with at a second diacid, or a diester of said second diacid, wherein said second diacid is different from said first diacid. Prepolymers produced from such processes and articles formed therefrom are also described. | 2012-02-02 |
20120027720 | PEPTIDE CONJUGATES - The present invention provides novel peptide conjugates. Peptide conjugates of the invention can be used as therapeutic agents. Peptide conjugates invention may also be used to deliver one or more additional active agents. The present invention also provides methods for the treatment of disease by administering to a subject suffering from the disease a composition comprising a peptide conjugate of the invention, optionally. | 2012-02-02 |
20120027721 | HCV Inhibitor and Therapeutic Agent Combinations - The present invention is directed to a combination product for treating or ameliorating hepatitis C virus (HCV) infection or disorders or symptoms associated therewith in a subject in need thereof comprising, a HCV inhibitor and one or more therapeutic agents selected from either or both a HCV protease inhibitor and one or more different therapeutic agents administered in combination in an effective amount to the subject. | 2012-02-02 |
20120027722 | HEPATITIS C VIRUS COMBINATION THERAPY - The present invention relates to methods and compositions for the treatment or prevention of hepatitis C virus comprising the administration of a combination of anti-hepatitis C virus antibodies and a-interferon. | 2012-02-02 |
20120027723 | TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION - The present invention relates to taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration. More particularly the invention relates to a substance selected from the group consisting of taurine, a taurine precursor, a taurine metabolite, a taurine derivative, a taurine analog and a substance required for the taurine biosynthesis for the prevention and treatment of a disease associated with retinal ganglion cell degeneration. | 2012-02-02 |
20120027724 | METHODS OF TREATING IMPAIRED GLUCOSE METABOLISM VIA ADMINISTRATION OF ALGAL BIOMASS - The invention is directed to methods of using | 2012-02-02 |
20120027725 | SAFE LENTIVIRAL VECTORS FOR TARGETED DELIVERY OF MULTIPLE THERAPEUTIC MOLECULES TO TREAT LIVER CANCER - The present application discloses a lentiviral transfer system for treating liver cancer which includes: (i) a self-inactivating transfer vector comprising: multiple gene units, wherein each gene unit includes a heterologous nucleic acid sequence operably linked to a regulatory nucleic acid sequence; and (ii) a helper construct which lacks a 5′ LTR, wherein the 5′ LTR has been replaced with a heterologous promoter, in which the helper construct further comprises: a lentiviral env nucleic acid sequence containing a deletion, wherein the deleted env nucleic acid sequence does not produce functional env protein; and a packaging signal contains a deletion, wherein the deleted packaging signal is nonfunctional. | 2012-02-02 |
20120027726 | Methods for Distributing High Levels of Therapeutic Agent Throughout the Cortex to Treat Neurological Disorders - The invention provides methods for treating neurological disorders, which involve administering therapeutic agents to the thalamus by convection enhanced delivery. | 2012-02-02 |
20120027727 | TARGETED NANOPARTICLES FOR CANCER AND OTHER DISORDERS - Targeted gene therapeutic systems are provided for the treatment of cancer, including viral particles. The viral particles are engineered to specifically deliver therapeutic or diagnostic agents to a disease site, such as cancer metastatic sites. Localized dosing regimens are provided to treat diseases such as cancer. | 2012-02-02 |
20120027728 | ADJUNCTIVE AGENT FOR LAVAGING THE ALIMENTARY CANAL COMPRISING BUTYRIC ACID BACTERIUM AND/OR LACTIC ACID BACTERIUM - The present invention provides an adjunctive agent and a method for lavaging the alimentary canal, which is able to reduce a dose of oral cleaning agent for lavaging the alimentary canal and is capable of realizing an excellent cleaning effect at the time of use of the oral cleaning agent. The adjunctive agent comprises butyric acid bacterium (for example, | 2012-02-02 |
20120027729 | METHODS FOR TREATING DIABETES - Transplantation of multipotent stromal cells (MSCs) into diabetic mice lowers blood sugar, increases blood insulin levels, increases the number and size of islets, and improves renal pathology. Accordingly, the invention provides methods for treating or preventing diabetes by administering isolated MSCs. The invention also provides methods for treating or preventing complications which arise from diabetes, including diabetic nephropathy, by transplanting isolated MSCs. | 2012-02-02 |
20120027730 | USES OF MESENCHYMAL STEM CELLS - The invention relates to the use of mesenchymal stem cells (MSCs) for treating systemic inflammatory response syndrome (SIRS) in a subject. The invention provides compositions, uses and methods for the treatment of SIRS. | 2012-02-02 |
20120027731 | HEMANGIO-COLONY FORMING CELLS - Methods of generating and expanding human hemangio-colony forming cells in vitro and methods of expanding and using such cells are disclosed. The methods permit the production of large numbers of hemangio-colony forming cells as well as derivative cells, such as hematopoietic and endothelial cells. The cells obtained by the methods disclosed may be used for a variety of research, clinical, and therapeutic applications. | 2012-02-02 |
20120027732 | THERMOREVERSIBLE COLLAGEN - This invention relates to collagen formulations. More particularly, this invention relates to thermoreversible collagen formulations and methods of their use and preparation. | 2012-02-02 |
20120027733 | COMPOSITIONS TO EFFECT NEURONAL GROWTH - Compositions containing neurogenic agents for inhibition of neuron death and inducing proliferation of neural cells are disclosed. | 2012-02-02 |
20120027734 | METHOD FOR ALLEVIATING INTESTINAL PROBLEMS AND NOVEL BACTERIAL STRAINS THEREFOR - The present invention relates to butyrate producing bacterial strains related to the species Buty{acute over (η)}coccus pullicaecorum to be used in the prevention and/or treatment of intestinal health problems. The present invention therefore provides methods and compositions that overcome the problems associated with the currently used methods for administering butyric acid in the treatment of intestinal health problems in humans and/or animals. | 2012-02-02 |
20120027735 | SYMBIOTIC MAPLE PRODUCT COMPOSITIONS AND METHODS - The present invention relates to novel maple product compositions. In particular, the present invention relates to new compositions comprising maple sap, maple concentrate, maple syrup or diluted maple syrup, and probiotics, prebiotics or combinations thereof. The present invention also discloses methods for the production of maple based products, including functional drinks, comprising a composition comprising maple sap, maple concentrate, maple syrup or dilutated maple syrup, and probiotics, prebiotics or combinations thereof, as a vehicle for the delivery of probiotics and prebiotics to the gastrointestinal tract. | 2012-02-02 |
20120027736 | ANTI-OBESITY AGENT AND ANTI-OBESITY FOOD - An anti-obesity agent containing, as an active ingredient, a microorganism which belongs to the species | 2012-02-02 |
20120027737 | USE OF PROBIOTICS TO AMELIORATE DIET-INDUCED INSULIN RESISTANCE - The invention relates to the use of a composition comprising probiotic bacteria that regulate expression of key components involved in diet-induced insulin resistance for ameliorating or preventing diet-induced insulin resistance. The use of the probiotic strain and/or a fraction of said strain and/or metabolite of said strain for the manufacture of a medicament or a food or feed product to ameliorate diet-induced insulin resistance and help to obtain optimal body weight of a mammal is disclosed. Preferably, the composition comprises at least one probiotic | 2012-02-02 |